United States Pharmaceuticals

Kalvista Pharmaceuticals Inc (KALV)

Track

Over the past 90 days, Kalvista Pharmaceuticals insiders have executed 14 transactions, all of which were sales totaling approximately $2.66 million. Key executives, including the CEO and Chief Development Officer, have offloaded shares as the stock reached its 52-week high. These transactions follow a positive earnings report in March, with no insider purchases recorded during this period.
Ticker: KALV Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Kalvista Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 27 May 2026
Value US$991,052.40 | Price 106.51 | Shares 8,508 (+21.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-29 2026-05-27 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
8,508 +21.6%
106.51
US$991,052 		8,508 +21.6% 106.51 US$991,052
2026-05-27 2026-05-27 PrS Proposed sale
3.9
CHRISTOPHER M YEA

Officer

Officer
49,914
288.51
US$2,566,765 		49,914 288.51 US$2,566,765
2026-05-27 2026-05-26 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
10,180 +16.0%
68.13
US$2,711,726 		10,180 +16.0% 68.13 US$2,711,726
2026-05-27 2026-05-26 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
1,966 -0.8%
26.78
US$52,645 		1,966 -0.8% 26.78 US$52,645
2026-05-27 2026-05-26 S Sale
1.6
Sweeny Nicole

Chief Commercial Officer

Officer
1,489 -2.4%
26.78
US$39,872 		1,489 -2.4% 26.78 US$39,872
2026-05-26 2026-05-22 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
10,926 -2.2%
26.78
US$292,646 		10,926 -2.2% 26.78 US$292,646
2026-05-26 2026-05-22 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
2,358 -1.0%
26.78
US$63,158 		2,358 -1.0% 26.78 US$63,158
2026-05-26 2026-05-22 S Sale
1.6
Sweeny Nicole

Chief Commercial Officer

Officer
1,861 -3.2%
26.78
US$49,846 		1,861 -3.2% 26.78 US$49,846
2026-05-26 2026-05-22 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
2,685 -1.8%
26.78
US$71,916 		2,685 -1.8% 26.78 US$71,916
2026-05-26 2026-05-22 S Sale
1.5
Piekos Brian

Chief Financial Officer

Officer
1,489 -6.4%
26.78
US$39,882 		1,489 -6.4% 26.78 US$39,882
2026-05-19 2026-05-18 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
1,129 -0.2%
26.76
US$30,212 		1,129 -0.2% 26.76 US$30,212
2026-05-19 2026-05-18 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
1,032 -0.7%
26.76
US$27,616 		1,032 -0.7% 26.76 US$27,616
2026-05-19 2026-05-18 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
1,108 -0.5%
26.76
US$29,650 		1,108 -0.5% 26.76 US$29,650
2026-05-13 2026-05-12 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
3,322 -0.7%
26.71
US$88,731 		3,322 -0.7% 26.71 US$88,731
2026-04-20 2026-04-17 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
2,686 -1.8%
20.22
US$54,301 		2,686 -1.8% 20.22 US$54,301
2026-04-20 2026-04-17 S Sale
1.6
Sweeny Nicole

Chief Commercial Officer

Officer
1,862 -3.5%
20.22
US$37,643 		1,862 -3.5% 20.22 US$37,643
2026-04-20 2026-04-17 S Sale
1.5
Piekos Brian

Chief Financial Officer

Officer
1,862 -9.3%
20.22
US$37,643 		1,862 -9.3% 20.22 US$37,643
2026-04-20 2026-04-17 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
9,550 -2.0%
20.22
US$193,066 		9,550 -2.0% 20.22 US$193,066
2026-03-27 2026-03-26 S Sale
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
3,183 -0.1%
19.12
US$60,859 		3,183 -0.1% 19.12 US$60,859
2026-03-27 2026-03-26 S Sale
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
15,417 -0.3%
18.82
US$290,148 		15,417 -0.3% 18.82 US$290,148
2026-03-27 2026-03-26 S Sale
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
21,386 -0.4%
17.76
US$379,815 		21,386 -0.4% 17.76 US$379,815
2026-03-27 2026-03-25 S Sale
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
160 -0.0%
17.53
US$2,805 		160 -0.0% 17.53 US$2,805
2026-03-27 2026-03-25 S Sale
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
174,485 -3.3%
16.95
US$2,957,521 		174,485 -3.3% 16.95 US$2,957,521
2026-03-10 2026-03-09 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
6,693 -1.5%
16.08
US$107,633 		6,693 -1.5% 16.08 US$107,633
2026-02-24 2026-02-23 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
5,354 -3.7%
15.57
US$83,345 		5,354 -3.7% 15.57 US$83,345
2026-02-24 2026-02-23 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
10,034 -2.2%
15.57
US$156,197 		10,034 -2.2% 15.57 US$156,197
2026-02-24 2026-02-23 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
4,347 -1.9%
15.57
US$67,669 		4,347 -1.9% 15.57 US$67,669
2026-02-24 2026-02-23 S Sale
1.5
Piekos Brian

Chief Financial Officer

Officer
1,767 -11.4%
15.57
US$27,507 		1,767 -11.4% 15.57 US$27,507
2026-02-24 2026-02-23 S Sale
1.6
Sweeny Nicole

Chief Commercial Officer

Officer
3,975 -7.8%
15.57
US$61,878 		3,975 -7.8% 15.57 US$61,878
2026-02-19 2026-02-18 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
1,163 -0.9%
15.00
US$17,445 		1,163 -0.9% 15.00 US$17,445
2026-02-19 2026-02-18 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
1,038 -0.2%
15.00
US$15,570 		1,038 -0.2% 15.00 US$15,570
2026-02-19 2026-02-18 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
1,109 -0.5%
15.00
US$16,635 		1,109 -0.5% 15.00 US$16,635
2026-02-13 2026-02-12 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
3,354 -0.8%
15.70
US$52,658 		3,354 -0.8% 15.70 US$52,658
2025-12-09 2025-12-08 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
7,294 -1.7%
16.51
US$120,424 		7,294 -1.7% 16.51 US$120,424
2025-12-04 2025-11-24 S Sale
1.6
Sweeny Nicole

Chief Commercial Officer

Officer
3,813 -8.8%
13.45
US$51,289 		3,813 -8.8% 13.45 US$51,289
2025-11-26 2025-11-24 S Sale
1.5
Piekos Brian

Chief Financial Officer

Officer
4,471 -29.8%
13.45
US$60,139 		4,471 -29.8% 13.45 US$60,139
2025-11-26 2025-11-24 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
4,331 -1.9%
13.45
US$58,256 		4,331 -1.9% 13.45 US$58,256
2025-11-26 2025-11-24 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
10,940 -2.6%
13.45
US$147,154 		10,940 -2.6% 13.45 US$147,154
2025-11-26 2025-11-24 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
5,296 -3.9%
13.45
US$71,236 		5,296 -3.9% 13.45 US$71,236
2025-11-19 2025-11-18 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
4,466 -1.1%
14.48
US$64,665 		4,466 -1.1% 14.48 US$64,665
2025-11-19 2025-11-18 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
3,075 -2.4%
14.48
US$44,524 		3,075 -2.4% 14.48 US$44,524
2025-11-19 2025-11-18 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
2,683 -2.0%
14.48
US$38,848 		2,683 -2.0% 14.48 US$38,848
2025-11-13 2025-11-12 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
3,328 -0.8%
11.55
US$38,438 		3,328 -0.8% 11.55 US$38,438
2025-09-09 2025-09-08 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
7,294 -1.8%
15.84
US$115,537 		7,294 -1.8% 15.84 US$115,537
2025-08-26 2025-08-25 S Sale
1.6
Sweeny Nicole

Chief Commercial Officer

Officer
1,480 -4.4%
13.42
US$19,862 		1,480 -4.4% 13.42 US$19,862
2025-08-26 2025-08-25 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
1,954 -1.5%
13.42
US$26,223 		1,954 -1.5% 13.42 US$26,223
2025-08-26 2025-08-25 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
2,336 -1.9%
13.42
US$31,349 		2,336 -1.9% 13.42 US$31,349
2025-08-25 2025-08-22 S Sale
1.6
Sweeny Nicole

Chief Commercial Officer

Officer
1,864 -6.1%
13.22
US$24,647 		1,864 -6.1% 13.22 US$24,647
2025-08-25 2025-08-22 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
2,942 -2.4%
13.22
US$38,901 		2,942 -2.4% 13.22 US$38,901
2025-08-25 2025-08-22 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
2,362 -1.8%
13.22
US$31,232 		2,362 -1.8% 13.22 US$31,232
2025-08-25 2025-08-22 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
10,940 -2.8%
13.22
US$144,657 		10,940 -2.8% 13.22 US$144,657
2025-08-19 2025-08-18 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
2,939 -2.5%
13.19
US$38,757 		2,939 -2.5% 13.19 US$38,757
2025-08-19 2025-08-18 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
2,649 -2.0%
13.19
US$34,932 		2,649 -2.0% 13.19 US$34,932
2025-08-19 2025-08-18 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
4,409 -1.2%
13.19
US$58,141 		4,409 -1.2% 13.19 US$58,141
2025-07-10 2025-07-09 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
30,250 -19.1%
15.69
US$474,698 		30,250 -19.1% 15.69 US$474,698
2025-07-10 2025-07-09 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
32,979 -8.2%
15.69
US$517,523 		32,979 -8.2% 15.69 US$517,523
2025-06-10 2025-06-09 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
7,169 -2.2%
14.50
US$103,950 		7,169 -2.2% 14.50 US$103,950
2025-05-27 2025-05-23 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
2,146 -1.9%
11.31
US$24,272 		2,146 -1.9% 11.31 US$24,272
2025-05-27 2025-05-23 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
1,926 -1.9%
11.31
US$21,782 		1,926 -1.9% 11.31 US$21,782
2025-05-23 2025-05-22 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
9,999 -3.2%
11.88
US$118,743 		9,999 -3.2% 11.88 US$118,743
2025-05-23 2025-05-22 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
2,317 -2.3%
11.88
US$27,516 		2,317 -2.3% 11.88 US$27,516
2025-05-23 2025-05-22 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
2,689 -2.4%
11.88
US$31,933 		2,689 -2.4% 11.88 US$31,933
2025-05-20 2025-05-19 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
3,808 -1.3%
11.84
US$45,097 		3,808 -1.3% 11.84 US$45,097
2025-05-20 2025-05-19 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
2,776 -2.5%
11.84
US$32,876 		2,776 -2.5% 11.84 US$32,876
2025-05-20 2025-05-19 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
2,600 -2.6%
11.84
US$30,791 		2,600 -2.6% 11.84 US$30,791
2025-04-11 2025-04-09 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
25,000 +0.5%
9.42
US$235,500 		25,000 +0.5% 9.42 US$235,500
2025-03-10 2025-03-07 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
6,669 -2.3%
11.97
US$79,828 		6,669 -2.3% 11.97 US$79,828
2025-02-25 2025-02-24 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
2,394 -2.3%
10.02
US$23,988 		2,394 -2.3% 10.02 US$23,988
2025-02-25 2025-02-24 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
1,918 -2.0%
10.02
US$19,218 		1,918 -2.0% 10.02 US$19,218
2025-02-19 2025-02-18 S Sale
3.9
Yea Christopher

CHIEF DEVELOPMENT OFFICER

Officer
2,601 -2.7%
9.82
US$25,553 		2,601 -2.7% 9.82 US$25,553
2025-02-19 2025-02-18 S Sale
3.5
Palleiko Benjamin L

CHIEF EXECUTIVE OFFICER

Executive Director
5,104 -1.8%
9.82
US$50,143 		5,104 -1.8% 9.82 US$50,143
2025-02-19 2025-02-18 S Sale
3.0
Audhya Paul K.

CHIEF MEDICAL OFFICER

Officer
3,125 -3.0%
9.82
US$30,701 		3,125 -3.0% 9.82 US$30,701
2025-02-14 2025-02-13 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
61,700 +1.2%
9.33
US$575,661 		61,700 +1.2% 9.33 US$575,661
2025-02-14 2025-02-12 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
100,000 +2.0%
9.23
US$923,000 		100,000 +2.0% 9.23 US$923,000
2025-02-11 2025-02-11 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
26,703 +0.5%
9.18
US$245,134 		26,703 +0.5% 9.18 US$245,134
Explore more

More insider trading research around Kalvista Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America